| Documents Related to the User Acceptance Testing of Tafenoquine |
Rejected |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Records Related to the 2019 Army Purchase of Tafenoquine (Arakoda™) |
Awaiting Appeal |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Tafenoquine Presentations to the U.S. FDA Antimicrobial Drugs Advisory Committee |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Correspondence Related to Proposed or Planned U.S. Military Policy for Use of Tafenoquine (Arakoda) |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Purchase Contracts, Orders, and Records Related to Tafenoquine (Arakoda) |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| WRAIR Center for Military Psychiatry & Neuroscience 125 Anniversary Presentations |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Documents Related to the USAMMDA "Tafenoquine Celebration" |
Partially Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| GWIRP FY10 ITEA Detailed Budget and Justification for Hubbard Detoxification Program (Scientology Purification) |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Additional GWIRP Progress Reports for Hubbard Detoxification Therapy (Scientology Purification) |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |
| Additional Documentation on Gulf War Illness Research Program for Scientology Detox Program |
Completed |
U.S. Army Medical Research and Materiel Command |
United States of America |